Impact of Sheath Type on Vascular and Bleeding Complications After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the MARVEL Registry Study

Overview

Journal Catheter Cardiovasc Interv

Specialty Cardiology & Vascular Diseases

Date 2025 Jan 3

PMID 39748665

Authors

Emily Pan

Herbert G Kroon

Pim A L Tonino

Giovanni Amoroso

Mika Laine

Evald H Christiansen

Stefan Toggweiler

Jur Ten Berg

Markus Malmberg

Ton Slagboom

Noriaki Moriyama

Christian J Terkelsen

Federico Moccetti

Livia Gheorghe

Darra Bigelow

John Webb

David Wood

Nicholas Van Mieghem

Mikko Savontaus

Affiliations

Soon will be listed here.

Abstract

Background: Vascular and bleeding complications remain a concern after transfemoral transcatheter aortic valve replacement (TAVR). The impact of the sheath type on these complications remains unclear.

Methods: The prospective MARVEL registry study analyzed enrolled 500 patients undergoing large-bore transfemoral procedures and arteriotomy closure with the MANTA vascular closure device from 10 hospitals in Europe and Canada. We stratified these patients according to type of sheath used (expandable or conventional). A propensity-matched analysis was performed using VARC-2 major or minor vascular and bleeding complications as the primary endpoint. The secondary endpoint was time to hemostasis.

Results: We identified 196 propensity-matched pairs. Major vascular complications occurred in 3.6% in the expandable sheath group and 4.1% in the conventional sheath group (p = 1.0). Minor vascular complications occurred in 5.6% in the expandable sheath group and 4.6% in the conventional sheath group (p = 0.819). There were no significant differences in bleeding complications between groups. Time to hemostasis after MANTA closure was significantly shorter in the expandable sheath group (30 vs. 60 s, p < 0.001).

Conclusions: A propensity-matched analysis demonstrated no significant differences in vascular complication rates with MANTA arteriotomy closure after removal of large bore expandable or conventional sheaths. Time to hemostasis was significantly shorter in the expandable sheath group.

References

Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

Mack M, Leon M, Thourani V, Makkar R, Kodali S, Russo M . Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1695-1705. DOI: 10.1056/NEJMoa1814052. View

Kappetein A, Head S, Genereux P, Piazza N, Van Mieghem N, Blackstone E . Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012; 42(5):S45-60. DOI: 10.1093/ejcts/ezs533. View

Dumpies O, Jobs A, Obradovic D, van Wiechen M, Hartung P, Rotta Detto Loria J . Comparison of plug-based versus suture-based vascular closure for large-bore arterial access: a collaborative meta-analysis of observational and randomized studies. Clin Res Cardiol. 2023; 112(5):614-625. PMC: 10160216. DOI: 10.1007/s00392-022-02145-5. View

Kroon H, Tonino P, Savontaus M, Amoroso G, Laine M, Christiansen E . Dedicated plug based closure for large bore access -The MARVEL prospective registry. Catheter Cardiovasc Interv. 2020; 97(6):1270-1278. PMC: 8246962. DOI: 10.1002/ccd.29439. View

Medranda G, Case B, Zhang C, Rappaport H, Weissman G, Bernardo N . Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience. Catheter Cardiovasc Interv. 2021; 98(3):580-585. DOI: 10.1002/ccd.29786. View

Ruge H, Burri M, Erlebach M, Lange R . Access site related vascular complications with third generation transcatheter heart valve systems. Catheter Cardiovasc Interv. 2020; 97(2):325-332. DOI: 10.1002/ccd.29095. View

Abdel-Wahab M, Hartung P, Dumpies O, Obradovic D, Wilde J, Majunke N . Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical Trial. Circulation. 2021; 145(3):170-183. DOI: 10.1161/CIRCULATIONAHA.121.057856. View

Reardon M, Van Mieghem N, Popma J, Kleiman N, Sondergaard L, Mumtaz M . Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017; 376(14):1321-1331. DOI: 10.1056/NEJMoa1700456. View

10.

Popma J, Deeb G, Yakubov S, Mumtaz M, Gada H, OHair D . Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1706-1715. DOI: 10.1056/NEJMoa1816885. View

11.

Ruge H, Burri M, Erlebach M, Lange R . Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR. Catheter Cardiovasc Interv. 2022; 99(5):1611-1618. DOI: 10.1002/ccd.30088. View

12.

Savvoulidis P, Nadir A, Mechery A, Doshi S . A very rare vascular complication of the Edwards expandable eSheath during transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2023; 101(3):660-667. DOI: 10.1002/ccd.30557. View

13.

Biancari F, Romppanen H, Savontaus M, Siljander A, Makikallio T, Piira O . MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation. Int J Cardiol. 2018; 263:29-31. DOI: 10.1016/j.ijcard.2018.04.065. View

14.

van Gils L, De Jaegere P, Roubin G, Van Mieghem N . The MANTA Vascular Closure Device: A Novel Device for Large-Bore Vessel Closure. JACC Cardiovasc Interv. 2016; 9(11):1195-6. DOI: 10.1016/j.jcin.2016.03.010. View

15.

Genereux P, Webb J, Svensson L, Kodali S, Satler L, Fearon W . Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012; 60(12):1043-52. DOI: 10.1016/j.jacc.2012.07.003. View

16.

van Wiechen M, Tchetche D, Ooms J, Hokken T, Kroon H, Ziviello F . Suture- or Plug-Based Large-Bore Arteriotomy Closure: A Pilot Randomized Controlled Trial. JACC Cardiovasc Interv. 2020; 14(2):149-157. DOI: 10.1016/j.jcin.2020.09.052. View

17.

Van Mieghem N, Latib A, van der Heyden J, van Gils L, Daemen J, Sorzano T . Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study. JACC Cardiovasc Interv. 2017; 10(6):613-619. DOI: 10.1016/j.jcin.2016.12.277. View

18.

Herrmann H, Mehran R, Blackman D, Bailey S, Mollmann H, Abdel-Wahab M . Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus. N Engl J Med. 2024; 390(21):1959-1971. DOI: 10.1056/NEJMoa2312573. View

19.

Dumpies O, Kitamura M, Majunke N, Hartung P, Haag A, Wilde J . Manta versus Perclose ProGlide vascular closure device after transcatheter aortic valve implantation: Initial experience from a large European center. Cardiovasc Revasc Med. 2021; 37:34-40. DOI: 10.1016/j.carrev.2021.06.134. View